Today: 19 June 2026

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology shares fell 0.3% to $83.22 Friday, extending their weekly loss to about 8%. SEC filings showed Chief Legal Officer Mark Casper sold 5,000 shares at $93.08 each. The drop follows Marvell’s $540 million deal to acquire XConn Technologies. Investors are watching for next week’s U.S. CPI report and Marvell’s earnings in early March.
10 January 2026
··
Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent shares rose 2.8% to $178.06 Friday, rebounding after a 9.6% drop the previous day. The move followed a softer U.S. jobs report that shifted rate expectations and lifted tech stocks. Coherent’s next earnings report is expected in early February, with investors watching U.S. CPI data on Jan. 13. The stock’s price-to-earnings ratio stands at 227.5, well above the industry median.
10 January 2026
··
Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon stock drops nearly 4% as tariff ruling stays unresolved — what to watch next

Lululemon shares fell 3.9% Friday, closing at $203.90 after dipping near $200. The drop followed uncertainty over U.S. Supreme Court action on tariffs, with a ruling possible Jan. 14. CEO Calvin McDonald will step down Jan. 31, with two interim co-CEOs named. Founder Chip Wilson has launched a proxy fight, nominating three directors amid pressure from Elliott Management.
10 January 2026
·
Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

Cisco stock dips after Supreme Court takes Falun Gong lawsuit; earnings date in focus

The U.S. Supreme Court will hear Cisco’s appeal in a lawsuit alleging it aided China’s crackdown on Falun Gong. Cisco shares fell 0.1% to $73.88 Friday, underperforming a record-setting S&P 500. The case tests whether U.S. firms can face lawsuits at home for alleged human rights abuses abroad. Investors await next week’s inflation data and Cisco’s Feb. 11 earnings call.
10 January 2026
·
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck shares fell 0.4% to $110.53 after reports it is in talks to acquire Revolution Medicines for up to $32 billion. The company faces new scrutiny over its Gardasil and RotaTeq vaccines after U.S. policy changes, with analysts estimating a $2 billion annual revenue impact. Wolfe Research upgraded Merck, citing progress on a subcutaneous version of Keytruda.
10 January 2026
····
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

BitMine Immersion Technologies shares dropped 3.9% to $30.06 Friday after naming Young Kim as CFO and COO and unveiling a pay package with stock awards and bonuses. The moves come ahead of a Jan. 15 shareholder vote on raising the company’s authorized share count. Trading volume reached 37.6 million shares. Investors face a Jan. 14 proxy deadline as debate continues over dilution and compensation.
10 January 2026
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power shares rose 4.3% to $20.51 in after-hours trading Friday after Bank of America upgraded the stock to neutral with a $28 target, citing funding and timing challenges. Meta’s new nuclear power deals fueled sector-wide gains, with Vistra and Oklo jumping nearly 14%. Options trading in NuScale surged 31% above average. The stock remains below key moving averages ahead of earnings expected March 2.
10 January 2026
····
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie shares fell 1.8% to $220.08 after the company cut its 2025 earnings forecast and denied takeover talks with Revolution Medicines. AbbVie now expects Q4 adjusted EPS of $2.61–$2.65, down from $3.32–$3.36, and full-year EPS of $9.90–$9.94. The company cited $1.265 billion in R&D and milestone charges. AbbVie said its fourth-quarter results are preliminary.
10 January 2026
···
1 … 926 927 928 929 930 … 2,084

Stock Market Today

  • Datadog Stock Valuation Near Fair Value After 75% Annual Gain
    June 19, 2026, 12:51 PM EDT. Datadog Inc (DDOG) shares closed at $223, reflecting a 75% gain over the past year. Despite robust growth in cloud infrastructure monitoring, valuation checks by Simply Wall St rate Datadog 0/6, signaling caution. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $220.81, implying the stock is roughly 1% overvalued, effectively fair valued within normal forecasting variance. Datadog's free cash flow is projected to rise significantly through 2030, supporting its current market price. Investors should monitor shifts in forecasts and valuations closely given the stock's high growth and pricing sensitivity.

Latest articles

NuScale Power halts after gains on Paragon SMR deal, Juneteenth pause

NuScale Power halts after gains on Paragon SMR deal, Juneteenth pause

19 June 2026
NuScale Power surged 13.54% to $11.74 after awarding Paragon a contract to complete key safety-system designs for its small modular reactor, but the stock still faces development risk with just $565,000 in Q1 revenue and a $776.9 million deficit; trading resumes Monday after the Juneteenth holiday.
Ford Shares Lose Ground in Shortened Trading Week as Juneteenth Shuts Markets

Ford Shares Lose Ground in Shortened Trading Week as Juneteenth Shuts Markets

19 June 2026
Ford shares slid 5% for the week to $14.06 as investors weighed a 13.6% drop in May U.S. sales, a lawsuit over California’s Lemon Law, and uncertainty over continued imports of China-built Lincoln Nautilus amid new U.S. supply-chain rules, despite Ford’s raised 2026 profit outlook and strong Q1 results.
Go toTop